CompletedNot Applicable

A Study of Flt3-Ligand Levels in Sjögrens Syndrome

Sweden30 participantsStarted 2009-06

Plain-language summary

The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * fulfill the ACR-criteria for primary Sjogrens syndrome, * age above 18 years old Exclusion Criteria: * other CNS-disease

What they're measuring

Correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome

Timeframe: June 2009 - June 2015

Trial details

NCT IDNCT01470638

SponsorGöteborg University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-04

View on ClinicalTrials.gov More Sjogrens Syndrome trials